Literature DB >> 20597942

Oral candidiasis and angular cheilitis.

Victoria Sharon1, Nasim Fazel.   

Abstract

Candidiasis, an often encountered oral disease, has been increasing in frequency. Most commonly caused by the overgrowth of Candida albicans, oral candidiasis can be divided into several categories including acute and chronic forms, and angular cheilitis. Risk factors for the development of oral candidiasis include immunosuppression, wearing of dentures, pharmacotherapeutics, smoking, infancy and old age, endocrine dysfunction, and decreased salivation. Oral candidiasis may be asymptomatic. More frequently, however, it is physically uncomfortable, and the patient may complain of burning mouth, dysgeusia, dysphagia, anorexia, and weight loss, leading to nutritional deficiency and impaired quality of life. A plethora of antifungal treatments are available. The overall prognosis of oral candidiasis is good, and rarely is the condition life threatening with invasive or recalcitrant disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20597942     DOI: 10.1111/j.1529-8019.2010.01320.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  16 in total

Review 1.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology.

Authors:  Jun-Bom Park; Suneela Prodduturi; Joe Morott; Vijay I Kulkarni; Melissa R Jacob; Shabana I Khan; Steven P Stodghill; Michael A Repka
Journal:  Expert Opin Drug Deliv       Date:  2014-08-29       Impact factor: 6.648

3.  A Case of Cheilocandidiasis.

Authors:  Soo Young Lee; Jin Young Choi; Jin-Wou Kim; Dong Soo Yu; Young Bok Lee
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

Review 4.  The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.

Authors:  Xiao-Qing Wei; Helen Rogers; Michael A O Lewis; David W Williams
Journal:  Clin Dev Immunol       Date:  2010-10-24

Review 5.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

6.  Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability.

Authors:  Curtis D Collins; Sarah Cookinham; Jeannina Smith
Journal:  Patient Prefer Adherence       Date:  2011-07-19       Impact factor: 2.711

7.  Anti-fungal resistance in candida isolated from oral and diaper rash candidiasis in neonates.

Authors:  Jasem Mohamadi; Mahsa Motaghi; Jafar Panahi; Mohamad Reza Havasian; Ali Delpisheh; Mitra Azizian; Iraj Pakzad
Journal:  Bioinformation       Date:  2014-11-27

8.  Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome.

Authors:  Katarzyna Błochowiak; Anna Olewicz-Gawlik; Adriana Polańska; Michalina Nowak-Gabryel; Jarosław Kocięcki; Henryk Witmanowski; Jerzy Sokalski
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

Review 9.  Biomaterials for the Prevention of Oral Candidiasis Development.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

Review 10.  Clinical Appearance of Oral Candida Infection and Therapeutic Strategies.

Authors:  Shankargouda Patil; Roopa S Rao; Barnali Majumdar; Sukumaran Anil
Journal:  Front Microbiol       Date:  2015-12-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.